Trump’s executive order to cap U.S. costs risks limiting the supply of new pharmaceuticals. President Donald Trump’s ...

3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

Ken Hall takes a closer look at GSK after the FTSE 100 pharmaceutical giant's positive first quarter earnings update.

Squeezed by insurers and middlemen, independent pharmacists such as Mr Jolley find themselves on the front lines of a tariff storm. Nearly everyone down the line — drugmakers, pharmacies, wholesalers, ...

An Enquirer analysis found that doctors, nurses and other practitioners received $136 million from pharma and biotech ...

McKesson Corporation announced its intention to separate its Medical-Surgical Solutions segment into an independent company.